Life ScienceCompany
Aevi Genomic Medicine M&A Summary
Aevi Genomic Medicine has acquired 1 company of its own.
Aevi Genomic Medicine’s largest acquisition to date was in 2015, when it acquired NeuroFix Therapeutics for $2M. Aevi Genomic Medicine has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Aevi Genomic Medicine Ownership
Who owns Aevi Genomic Medicine?
Aevi Genomic Medicine is owned by Avalo Therapeutics. It was acquired on December 5, 2019.
Aevi Genomic Medicine Business Overview
Where is Aevi Genomic Medicine headquartered?
Aevi Genomic Medicine is headquartered in Wayne, Pennsylvania.
How many employees does Aevi Genomic Medicine have?
Aevi Genomic Medicine has 14 employees.
What sector is Aevi Genomic Medicine in?
Aevi Genomic Medicine is a life science company.
When was Aevi Genomic Medicine founded?
Aevi Genomic Medicine was founded in 2000.
M&A Summary
-
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1